| Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes L Zhu, ZG She, X Cheng, JJ Qin, XJ Zhang, J Cai, F Lei, H Wang, J Xie, ... Cell metabolism 31 (6), 1068-1077. e3, 2020 | 1842 | 2020 |
| Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with … P Zhang, L Zhu, J Cai, F Lei, JJ Qin, J Xie, YM Liu, YC Zhao, X Huang, ... Circulation research 126 (12), 1671-1681, 2020 | 1329 | 2020 |
| In-hospital use of statins is associated with a reduced risk of mortality among individuals with COVID-19 XJ Zhang, JJ Qin, X Cheng, L Shen, YC Zhao, Y Yuan, F Lei, MM Chen, ... Cell metabolism 32 (2), 176-187. e4, 2020 | 507 | 2020 |
| Longitudinal association between markers of liver injury and mortality in COVID‐19 in China F Lei, YM Liu, F Zhou, JJ Qin, P Zhang, L Zhu, XJ Zhang, J Cai, L Lin, ... Hepatology 72 (2), 389-398, 2020 | 469 | 2020 |
| Redefining cardiac biomarkers in predicting mortality of inpatients with COVID-19 JJ Qin, XU Cheng, F Zhou, F Lei, G Akolkar, J Cai, XJ Zhang, A Blet, J Xie, ... Hypertension 76 (4), 1104-1112, 2020 | 182 | 2020 |
| Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes X Cheng, YM Liu, H Li, X Zhang, F Lei, JJ Qin, Z Chen, KQ Deng, L Lin, ... Cell metabolism 32 (4), 537-547. e3, 2020 | 158 | 2020 |
| Perioperative presentation of COVID‐19 disease in a liver transplant recipient J Qin, H Wang, X Qin, P Zhang, L Zhu, J Cai, Y Yuan, H Li Hepatology 72 (4), 1491-1493, 2020 | 132 | 2020 |
| The neutrophil-to-lymphocyte ratio determines clinical efficacy of corticosteroid therapy in patients with COVID-19 J Cai, H Li, C Zhang, Z Chen, H Liu, F Lei, JJ Qin, YM Liu, F Zhou, X Song, ... Cell metabolism 33 (2), 258-269. e3, 2021 | 119 | 2021 |
| Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease W Wang, M Hu, H Liu, X Zhang, H Li, F Zhou, YM Liu, F Lei, JJ Qin, ... Cell metabolism 33 (10), 1943-1956. e2, 2021 | 99 | 2021 |
| Kidney function indicators predict adverse outcomes of COVID-19 YM Liu, J Xie, MM Chen, X Zhang, X Cheng, H Li, F Zhou, JJ Qin, F Lei, ... Med 2 (1), 38-48. e2, 2021 | 83 | 2021 |
| Comparative impacts of ACE (angiotensin-converting enzyme) inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality F Zhou, YM Liu, J Xie, H Li, F Lei, H Yang, JJ Qin, J Cai, XJ Zhang, B Wu, ... Hypertension 76 (2), e15-e17, 2020 | 73 | 2020 |
| Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages X Zhang, J Li, JJ Qin, WL Cheng, X Zhu, FH Gong, Z She, Z Huang, H Xia, ... Journal of Lipid Research 58 (5), 895-906, 2017 | 70 | 2017 |
| The ubiquitin E3 ligase TRAF6 exacerbates ischemic stroke by ubiquitinating and activating Rac1 T Li, JJ Qin, X Yang, YX Ji, F Guo, WL Cheng, X Wu, FH Gong, Y Hong, ... Journal of Neuroscience 37 (50), 12123-12140, 2017 | 61 | 2017 |
| Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1 JJ Qin, W Mao, X Wang, P Sun, D Cheng, S Tian, XY Zhu, L Yang, ... Journal of Hepatology 69 (5), 1110-1122, 2018 | 57 | 2018 |
| Hepatic oncostatin M receptor β regulates obesity-induced steatosis and insulin resistance P Luo, PX Wang, ZZ Li, XJ Zhang, X Jiang, J Gong, J Qin, J Guo, X Zhu, ... The American Journal of Pathology 186 (5), 1278-1292, 2016 | 37 | 2016 |
| Interferon regulatory factor 4 inhibits neointima formation by engaging Krüppel-like factor 4 signaling WL Cheng, ZG She, JJ Qin, JH Guo, FH Gong, P Zhang, C Fang, S Tian, ... Circulation 136 (15), 1412-1433, 2017 | 35 | 2017 |
| No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19 JH Zhou, B Wu, WX Wang, F Lei, X Cheng, JJ Qin, JJ Cai, XJ Zhang, ... World journal of clinical cases 8 (22), 5576, 2020 | 34 | 2020 |
| High remnant cholesterol level potentiates the development of hypertension MM Chen, X Huang, C Xu, XH Song, YM Liu, D Yao, H Lu, G Wang, ... Frontiers in endocrinology 13, 830347, 2022 | 29 | 2022 |
| Reduced atherosclerosis lesion size, inflammatory response in miR-150 knockout mice via macrophage effects FH Gong, WL Cheng, H Wang, M Gao, JJ Qin, Y Zhang, X Li, X Zhu, H Xia, ... Journal of Lipid Research 59 (4), 658-669, 2018 | 27 | 2018 |
| LILRB4 deficiency aggravates the development of atherosclerosis and plaque instability by increasing the macrophage inflammatory response via NF-κB signaling Z Jiang, JJ Qin, Y Zhang, WL Cheng, YX Ji, FH Gong, XY Zhu, Y Zhang, ... Clinical Science 131 (17), 2275-2288, 2017 | 27 | 2017 |
